Restorative Cardiovascular Devices

Xeltis developed the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Xeltis’ devices naturally evolve into living blood vessels
or heart valves, when colonized by patient’s own tissue.

This therapeutic approach is called
Endogenous Tissue Restoration (ETR).


Endogenous Tissue Restoration

Play the video

With ETR, the patient’s natural healing system develops tissue that pervades Xeltis’ device, forming a new, natural and fully functional blood vessel or heart valve within it.

As ETR occurs, Xeltis implants are gradually absorbed by the body.

ETR is enabled by the porous structure of Xeltis’ devices, which are made of bioabsorbable polymers, based on Nobel-prize awarded science.

The Xeltis technology platform comprises investigational heart valve and blood vessel devices that are not available for sale.